XML 50 R31.htm IDEA: XBRL DOCUMENT v3.25.0.1
SCHEDULE II. CONDENSED FINANCIAL INFORMATION OF REGISTRANT
 12 Months Ended
Dec. 31, 2024
Condensed Financial Information Disclosure [Abstract]  
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
SCHEDULE II
RENAISSANCERE HOLDINGS LTD.
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
RENAISSANCERE HOLDINGS LTD.
BALANCE SHEETS
AT DECEMBER 31, 2024 AND 2023
(PARENT COMPANY)
(THOUSANDS OF UNITED STATES DOLLARS)
 
 At December 31,
 20242023
Assets
Fixed maturity investments trading, at fair value - amortized cost $153,742 at December 31, 2024 (2023 - $Nil)
$153,504 $— 
Short term investments, at fair value - amortized cost $131,232 at December 31, 2024 (2023 - $277,917)
131,236 277,917 
Total investments284,740 277,917 
Cash and cash equivalents
20,054 45,080 
Investments in subsidiaries
10,732,129 9,632,226 
Due from subsidiaries
7,919 52,816 
Accrued investment income
1,052 — 
Deferred tax asset
10,334 33,646 
Receivable for investments sold
1,329 2,849 
Other assets
681,322 660,818 
Goodwill and other intangible assets
98,662 101,509 
Total assets$11,837,541 $10,806,861 
Liabilities and Shareholders’ Equity
Liabilities
Debt
$1,138,119 $1,136,260 
Due to subsidiaries
17,051 136,729 
Other liabilities
108,359 78,915 
Total liabilities1,263,529 1,351,904 
Shareholders’ Equity
Preference shares: $1.00 par value - 30,000 shares issued and outstanding at December 31, 2024 (2023 - 30,000)
750,000 750,000 
Common shares: $1.00 par value - 50,180,987 shares issued and outstanding at December 31, 2024 (2023 - 52,693,887)
50,181 52,694 
Additional paid-in capital1,512,435 2,144,459 
Accumulated other comprehensive income (loss)(14,756)(14,211)
Retained earnings8,276,152 6,522,015 
Total shareholders’ equity attributable to RenaissanceRe
10,574,012 9,454,957 
Total liabilities and shareholders’ equity$11,837,541 $10,806,861 
SCHEDULE II
RENAISSANCERE HOLDINGS LTD.
CONDENSED FINANCIAL INFORMATION OF REGISTRANT – CONTINUED
 
RENAISSANCERE HOLDINGS LTD.
STATEMENTS OF OPERATIONS
FOR THE YEARS ENDED DECEMBER 31, 2024, 2023 AND 2022
(PARENT COMPANY)
(THOUSANDS OF UNITED STATES DOLLARS) 
 Year ended December 31,
 202420232022
Revenues
Net investment income
$58,166 $97,395 $46,966 
Net foreign exchange gains (losses)
(23,916)1,129 (46,796)
Other income (loss)
(95)(907)— 
Net realized and unrealized gains (losses) on investments(4,840)(73,572)(3,017)
Total revenues29,315 24,045 (2,847)
Expenses
Operational expenses
15,866 32,066 14,818 
Corporate expenses
86,314 98,493 39,614 
Interest expense
59,384 40,416 15,315 
Total expenses161,564 170,975 69,747 
Income (loss) before equity in net income (loss) of subsidiaries
(132,249)(146,930)(72,594)
Equity in net income (loss) of subsidiaries2,017,805 2,708,061 (988,610)
Income (loss) before taxes
1,885,556 2,561,131 (1,061,204)
Income tax benefit (expense)
(15,196)— — 
Net income (loss)1,870,360 2,561,131 (1,061,204)
Dividends on preference shares
(35,375)(35,375)(35,375)
Net income (loss) available (attributable) to RenaissanceRe common shareholders$1,834,985 $2,525,756 $(1,096,579)

RENAISSANCERE HOLDINGS LTD.
STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
FOR THE YEARS ENDED DECEMBER 31, 2024, 2023 AND 2022
(PARENT COMPANY)
(THOUSANDS OF UNITED STATES DOLLARS) 
Year ended December 31,
202420232022
Comprehensive income (loss)
Net income (loss)$1,870,360 $2,561,131 $(1,061,204)
Change in net unrealized gains (losses) on investments, net of tax1,045 1,082 (4,923)
Foreign currency translation adjustments, net of tax(1,590)169 370 
Comprehensive income (loss) attributable to RenaissanceRe$1,869,815 $2,562,382 $(1,065,757)
SCHEDULE II
RENAISSANCERE HOLDINGS LTD.
CONDENSED FINANCIAL INFORMATION OF REGISTRANT – CONTINUED
 
RENAISSANCERE HOLDINGS LTD.
STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 2024, 2023 AND 2022
(PARENT COMPANY)
(THOUSANDS OF UNITED STATES DOLLARS)
 Year ended December 31,
 202420232022
Cash flows provided by (used in) operating activities:
Net income (loss)$1,870,360 $2,561,131 $(1,061,204)
Less: equity in net income (loss) of subsidiaries
(2,017,805)(2,708,061)988,610 
(147,445)(146,930)(72,594)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Net realized and unrealized (gains) losses on investments334 67,868 2,051 
Other142,051 72,691 36,601 
Net cash provided by (used in) operating activities(5,060)(6,371)(33,942)
Cash flows provided by (used in) investing activities:
Proceeds from sales and maturities of fixed maturity investments trading
309,490 1,613,740 198,341 
Purchases of fixed maturity investments trading(387,276)(1,505,160)(375,804)
Net sales (purchases) of short term investments147,296 (211,370)(21,037)
Dividends and return of capital from subsidiaries1,079,438 1,097,301 1,009,108 
Contributions to subsidiaries(247,147)(169,204)(349,336)
Due to (from) subsidiary
(115,041)(7,088)(178,470)
Due to (from) subsidiary for the purchase of Validus Specialty
— (45,467)— 
Purchase of Validus Holdings and Talbot Treaty Renewal Rights
— (2,689,533)— 
Net cash provided by (used in) investing activities786,760 (1,916,781)282,802 
Cash flows provided by (used in) financing activities:
Dividends paid – RenaissanceRe common shares(80,850)(75,112)(64,675)
Dividends paid – preference shares(35,375)(35,375)(35,396)
RenaissanceRe common share repurchases(666,921)— (166,664)
RenaissanceRe common share issuance, net of expenses
— 1,351,608 — 
Issuance of debt, net of expenses— 740,581 — 
Taxes paid on withholding shares(23,580)(20,518)(10,911)
Net cash provided by (used in) financing activities(806,726)1,961,184 (277,646)
Effect of exchange rate changes on foreign currency cash— — — 
Net increase (decrease) in cash and cash equivalents(25,026)38,032 (28,786)
Cash and cash equivalents, beginning of year45,080 7,048 35,834 
Cash and cash equivalents, end of year$20,054 $45,080 $7,048